MacroGenics Provides Update on Corporate Progress and Third Quarter 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
Macrogenics (MGNX) Tops Q3 EPS by 7c
November 6, 2019 5:47 PM ESTMacrogenics (NASDAQ: MGNX) reported Q3 EPS of ($0.91), $0.07 better than the analyst estimate of ($0.98). Revenue for the quarter came in at $18.7 million versus the consensus estimate of $19.12 million.
MacroGenics most advanced programs are positioned to initiate or complete registration-directed studies over the... More

